Side-by-side comparison of AI visibility scores, market position, and capabilities
News Corp Class A shares (one vote each); same underlying $10.1B FY2024 revenue business as NWS; WSJ, Dow Jones, HarperCollins, REA Group; Murdoch family Class B supervoting control structure.
News Corp Class A (Nasdaq: NWSA) represents the voting shares of News Corp, a global media and information services company controlled by the Murdoch family through Class B supervoting shares, founded as the successor entity when the original News Corporation was separated in 2013 into Fox Corporation (broadcast and cable news entertainment) and News Corp (publishing, digital real estate, and information services). Headquartered in New York City, News Corp generated approximately $10.1 billion in revenues for fiscal year 2024 (ending June 2024) under CEO Robert Thomson. The Class A shares carry one vote per share, while Rupert Murdoch's family trust holds Class B shares with 10 votes per share that maintain controlling governance—a structure common in media companies founded by entrepreneur families who wish to retain editorial and strategic control through public capital markets financing.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.